Pharma Journalist -

SMi Reports: The morning session on day two of SMi’s RNA Therapeutics conference will pay a particular focus to “Downregulating Therapeutic Technologies”. SMi are proud to host the…
Read More...

Last week marked an exciting time for the RAS community with Boehringer Ingelheim advancing the first Pan-KRAS inhibitor into clinical testing. Don’t miss this unique opportunity to…
Read More...

SMi Reports: the agenda and speaker overview of the upcoming SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020, in London is now available to view. SMi Group is delighted…
Read More...

SMi has released an exclusive interview with industry expert John Lisman, Attorney, Consultant and Trainer of Lisman Legal Life sciences B.V., ahead of the upcoming Parallel Trade…
Read More...

SMi has released an exclusive interview with industry expert Torsten Kneuss, Quality Assurance Manager Combination Products of Bayer, ahead of the upcoming Pre-Filled Syringes and…
Read More...

Amgen announced that it has entered into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand its oncology presence in China, the world's…
Read More...

Tmunity Therapeutics, in pursuit of its vision to save and improve lives by delivering the full potential of next-generation T-cell immunotherapy, closed a $75 million Series B…
Read More...

Dicerna Pharmaceuticals, Inc. announced a research collaboration and licensing agreement with Roche to develop novel therapies for the treatment of chronic hepatitis B virus (HBV)…
Read More...

Daiichi Sankyo Company, Limited and Sarah Cannon Research Institute (Sarah Cannon) announced that the first patient has been dosed in a first-in-human phase 1/2 study evaluating…
Read More...

NuChem Therapeutics, a drug discovery and development contract research organization (CRO) located in Montreal, specializing in synthetic and medicinal chemistry services, has just…
Read More...